Immunocore Holdings Plc (IMCR)
32.93
+0.25
(+0.76%)
USD |
NASDAQ |
Feb 23, 16:00
32.91
-0.02
(-0.06%)
After-Hours: 19:59
Immunocore Holdings Total Liabilities (Quarterly) : 705.94M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Silence Therapeutics Plc | 72.73M |
| Adaptimmune Therapeutics Plc | 201.59M |
| Biodexa Pharmaceuticals Plc | -- |
| Oxford Biomedica Plc | -- |
| NuCana Plc | 8.601M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.102B |
| Shareholders Equity (Quarterly) | 396.56M |
| Debt to Equity Ratio | 1.099 |
| Current Ratio | 6.004 |
| Net Debt Paydown Yield | 0.40% |